The short answer.
If you are here because of the renewal, start with the thing that makes this category unusual. You cannot benchmark your way out of it. ModMed publishes no rate card, and neither does Nextech, athenahealth, eClinicalWorks or NextGen Healthcare. Exactly two names on the list below publish an actual figure on their own websites that a practice administrator can check without entering a sales cycle, and they are Carepatron and Edvak, both of which sit at a different scale and a different certification posture than EMA. So the standard negotiating move, collecting rival quotes to build leverage, produces less leverage here than in almost any other category of business software. The strongest number you can carry into a renewal conversation is not a competitor's quote you cannot get. It is your own total cost across the remaining contract and the one after it, which is the thing this page is built to hand you.
If you are here because the price went up, the answer is different and more useful, because ModMed does publish the mechanism even though it does not publish the number. Its own revenue cycle management terms state that fees may be changed on at least thirty days prior written notice, with the change taking effect at the beginning of the next renewal term. Its own Costs and Limitations disclosure states that the fees and costs it describes are subject to change. Nobody, anywhere, publishes a percentage, and we looked hard enough at that question to be confident saying so rather than filling the gap with an invented figure. What that means practically is that the increase you received is contractually normal, and there is no public schedule to argue it against, which is exactly the position that sends practice administrators looking for a way out.
And if you are here because you want to know whether a custom build can replace ModMed, the honest answer is no, not fully, and any page that tells you otherwise is either selling something or does not understand what ONC certification is. The certified electronic health record has to stay: the clinical documentation, the e-prescribing, the certification criteria your MIPS reporting rests on, the legal medical record. What a commissioned build honestly replaces is the operational layer that has accumulated around it. Scheduling and rescheduling. Intake and forms. Eligibility and prior authorization tracking. Billing operations and denial follow up. Practice reporting. Patient communication. For a qualifying multi provider group the realistic outcome is fewer seats on the certified system, kept for the clinical staff who genuinely need them, plus a layer you own for everything else. That is a smaller, more defensible claim than the one you will read elsewhere, and it is the only one we will make.
One more thing before the detail, because it changes how you should read every comparison article about this product, including this one. Of the guides a practice administrator is most likely to land on, one of the most complete is published by Pabau, which is itself a competing platform in its own comparison, and another is published by Edvak, which sells a dermatology electronic health record directly against ModMed and recommends it inside the same comparison. Neither of those facts makes their content worthless. Pabau in particular does something genuinely creditable and rare, which is to state plainly on its own site that it does not carry US ONC certification, a disclosure that costs it deals. But you should know who is holding the pen. We are not neutral either. We sell commissioned builds, and the ninth option on this page is us. The difference we can offer is that every number here is labelled with where it came from, and the sections that argue against hiring us are as long as the ones that argue for it.
What ModMed actually does well.
Worth saying before anything else, because a page that only attacks reads as an advertisement and deserves to be read that way. EMA sits at the centre of specialty ambulatory medicine for reasons that are real, and a practice administrator who has run it for eight years does not need us to explain them. Still, they are worth writing down, because the strongest version of the leaving argument has to survive them.
It is genuinely certified, and that is not a marketing checkbox. ModMed's own Costs and Limitations of Certified Health IT document lists specific 2015 Edition Cures Update certified criteria by their Code of Federal Regulations citation, including 170.315(a)(2) computerized provider order entry for laboratory, 170.315(b)(1) transitions of care, 170.315(b)(2) clinical information reconciliation and incorporation, 170.315(b)(3) electronic prescribing, 170.315(b)(6) data export, 170.315(e)(1) view, download and transmit to a third party, and the 170.315(g)(7), (g)(9) and (g)(10) application access and standardised API criteria. VERIFIED, read directly from modmed.com on August 30, 2026. That certification is the reason your MIPS reporting works, the reason your patient portal satisfies the access requirement, and the reason the clinical record is defensible. It is also the single hardest thing on this page to replace, and we are not going to pretend otherwise.
It is specialty native rather than specialty adapted. ModMed's own dermatology page describes touch based documentation, built in dermatology ICD-10 codes, the ability to recall laser settings and preferred anaesthesia for biopsies, in house dermatopathology receipt and billing through its Pathology module, and cosmetic visit billing inside Practice Management. VERIFIED, read from modmed.com/specialties/dermatology/ on August 30, 2026. A generalist ambulatory system can be configured toward that. It does not arrive there.
The suite is genuinely integrated, and integration has real value. On its own site ModMed describes an integrated stack of patient engagement, clinical documentation, practice management, analytics and revenue cycle management, plus Payment Processing, Marketing Services and Procurement Services. When a patient reschedules, when a claim is denied, when a supply is ordered, those events sit in one system with one support number. Practices that have lived through a best of breed stack of six vendors pointing at each other during an outage know exactly what that is worth.
Its AI is inside the product rather than sold as a separate subscription, at least as ModMed describes it. This is the part that cuts against our own argument and we are stating it plainly rather than burying it. ModMed's own dermatology page says of ModMed Scribe 2.0: unlock the power of AI built directly into our EMA EHR, no additional software or integrations required. VERIFIED, read on August 30, 2026. It also reports over 1,800,000 patient visits captured by ModMed Scribe 2.0. The standard argument that incumbents tax you per seat for AI does not obviously apply here in the form it applies elsewhere, because ModMed publishes no price for Scribe at all and describes it as built in rather than added on. We could not find a Scribe price anywhere, on ModMed's site or off it. What we can document as a genuinely separate per provider fee is e-prescribing of controlled substances, and that is a certification capability rather than an AI module. If somebody sells you an alternatives page that claims a specific ModMed AI surcharge, ask them for the source, because we went looking for one and there is not a published number to find.
Institutional knowledge is a real asset on the balance sheet nobody keeps. A biller who has worked denials in EMA for six years is fast in it, and that speed does not appear on any comparison table. Neither does the cost of taking it away from her. Any honest total cost model has to sit next to that, which is why the migration section further down spends as much time on the parallel run as on the export.
None of that is the argument on this page. The argument on this page is about a price you cannot check against anything public, contract mechanics you probably have not read since signing, and the specific question of whether the operational layer around the certified record is worth renting at a per provider rate forever. A system can be excellent and still be the wrong thing to have no alternative to.
Why specialty practices start looking for a way out.
The renewal, and the fact that you cannot price it. ModMed publishes nothing. We loaded modmed.com and modmed.com/specialties/dermatology/ on August 30, 2026 and confirmed it: no price, no cost, no dollar figure in the visible text of either page. We then read ModMed's own Costs and Limitations of Certified Health IT document, the disclosure document that exists under the certification programme precisely to tell buyers what a certified system costs, and it contains no dollar figure either, for any capability, anywhere in five pages. What it says about EMA's fees, verbatim, is that Modernizing Medicine charges certain one-time and ongoing fees in connection with EMA. That is the entirety of the public disclosure. When your quote arrives, there is no public number to hold it against, and the practice down the road cannot help you either, because they signed a contract with the same silence in it.
The per named user licence, which taxes exactly the thing a growing group does. ModMed's own disclosure states that its contracts set forth, among other things, product pricing and payment terms and limitations on the use of products and services, giving as its own example limitations on number and type of users. VERIFIED. The revenue cycle management terms go further and say the number of users shall not exceed the number specified in the agreement, that increases run through a signed Add-On Addendum, and that ModMed may make any increase in the number of users contingent on payment of fees it deems appropriate, including without limitation activation fees. VERIFIED, both read from modmed.com on August 30, 2026. Hire an associate and the bill moves. Add a part time cosmetic injector and the bill moves. That is not a criticism of ModMed, it is simply what per seat licensing is, and it is the mechanic that makes the ownership arithmetic further down work at scale and fail at one provider.
The module gate. Here is the line most practices have never read: clients must subscribe to EMA in order to subscribe to additional products, modules, and services. VERIFIED, ModMed's own Costs and Limitations document, quoted verbatim. That is a structural fact worth sitting with. A practice cannot buy the cheaper piece it actually wants without holding the base licence first. There is no a la carte path in. Whatever you decide about the operational layer, the certified core is the toll booth.
Fees that are contractually allowed to move, with no published schedule. ModMed's revenue cycle management terms state that it may change fees by providing at least thirty days prior written notice, with the changes taking effect at the beginning of the next renewal term. VERIFIED. Its Costs and Limitations disclosure closes by saying the fees and costs set forth above are subject to change. VERIFIED. Both statements are perfectly ordinary contract language. What makes them consequential here is the absence of anything else: no published rate, no published escalation cap, no published schedule, so the only benchmark for next year's number is this year's invoice.
Separately priced everything. E-prescribing of controlled substances carries a per provider subscription fee of its own, usually structured as a monthly per provider fee, with a possible additional set-up fee. VERIFIED, ModMed's own disclosure. Revenue cycle management runs under a separate agreement with its own fee schedule. Customisations and additional modules, in ModMed's own words, shall be separately negotiated and priced, with ModMed determining in its sole discretion what counts as a customisation. VERIFIED. Analytics functionality beyond a baseline may require the payment of additional fees. VERIFIED. None of those carry a published number either. The practical effect is that the quote you negotiated is the floor of what the relationship costs, not the ceiling.
The operational layer keeps growing and it is the expensive part. Notice what ModMed's own marketing says its newest AI assistants are for: patient scheduling and communication, eligibility processing, prior authorization, and claim denial appeals. VERIFIED, quoted from ModMed's own site on August 30, 2026. Those are not clinical documentation tasks. They are administrative operations, and the vendor is telling you plainly that this is where the labour is. That agreement between us and them is the whole basis of the ownership argument on this page. We simply disagree about who should own the software that does it.
Ownership churn above you. ModMed has published two press releases on its own site about a change of control: one titled ModMed, a Leading Healthcare SaaS Platform, Announces Significant Majority Growth Investment from Clearlake Capital, and a second titled Clearlake Capital Completes Majority Investment in ModMed to Fund Growth. Both are on modmed.com and both loaded for us on August 30, 2026. VERIFIED that ModMed published them; we could not read the article bodies through our tooling, so we are reporting the titles and the URLs and nothing more. We are deliberately not printing a valuation figure, because we could not read one off ModMed's own release, and we are deliberately not claiming that any ownership change caused any price change, because no source we found documents that link. State it as what it is. The company that holds your clinical record changed majority owner in 2025, and you were not consulted, and that is the ordinary condition of renting software rather than owning it.